Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CK.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BE.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BE.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.16.1 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.16.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.16.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.16.1 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.9.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.9.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.9.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.9.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.72ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.72ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.72ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.72NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.20ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.20NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.73ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.73ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.73ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.73NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDZORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDZENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDZENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDZNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XEBORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XEBENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XEBENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XEBNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.263ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.263ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.263ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.263NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.180ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.180ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.180ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.180NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.464ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.464ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.464ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.464NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.234ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used